Corrigendum

Abstract

Hepatology ResearchVolume 52, Issue 12 p. 1076-1076 CORRIGENDUMFree Access Corrigendum This article corrects the following: Sequential therapy including regorafenib for unresectable hepatocellular carcinoma: Effect of early relative changes in hepatic functional reserve after regorafenib administration on prognosis Hironori Ochi, Joji Tani, Tetsu Tomonari, Tatsuya Taniguchi, Yohei Koizumi, Akira Hirose, Chikara Ogawa, Atsushi Hiraoka, Akihiro Morishita, Akio Moriya, Masashi Hirooka, Akihiro Deguchi, SYMPLE Study Group, Volume 51Issue 12Hepatology Research pages: 1219-1228 First Published online: September 29, 2021 First published: 11 November 2022 https://doi.org/10.1111/hepr.13853AboutSectionsPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat In the article entitled “Sequential therapy including regorafenib for unresectable hepatocellular carcinoma: Effect of early relative changes in hepatic functional reserve after regorafenib administration on prognosis”,1 in the author byline the first name of the co-author ‘Akihiro Morishita’ has been corrected as below: Asahiro Morishita The authors apologize for this error. REFERENCE 1Ochi H, Tani J, Tomonari T, Taniguchi T, Koizumi Y, Hirose A, et al. Sequential therapy including regorafenib for unresectable hepatocellular carcinoma: effect of early relative changes in hepatic functional reserve after regorafenib administration on prognosis. Hepatol Res. 2021; 51(12): 1219– 28. https://doi.org/10.1111/hepr.13713 Volume52, Issue12December 2022Pages 1076-1076 ReferencesRelatedInformation